Folidex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folidex

What is Folidex?

Folidex is an oral vitamin supplement containing folic acid, a synthetic form of folate. Folate is a water-soluble B-vitamin, also known as vitamin B9, which occurs naturally in various foods. It plays a fundamental role in several biological processes within the body.

Composition and Mechanism

The active ingredient in Folidex is folic acid. Once ingested, the body converts folic acid into its active metabolites. These substances are essential for the synthesis of nucleic acids, such as DNA and RNA, which carry genetic information. Because of this role in genetic synthesis, folic acid is a critical component for cellular division and the growth of new tissues.

Primary Functions

Folidex is primarily used to support physiological functions that require rapid cell turnover. Its main functions include:

  • Red Blood Cell Production: Folic acid is necessary for the proper formation and maturation of red blood cells. A deficiency in this vitamin can lead to the production of abnormally large red blood cells that do not function efficiently.
  • Nucleic Acid Synthesis: It acts as a coenzyme in the transfer of single-carbon units, a process vital for creating the building blocks of DNA.
  • Amino Acid Metabolism: It assists in the conversion and metabolism of certain amino acids, including the regulation of homocysteine levels in the blood.

Role in Preconception and Pregnancy

One of the most significant applications of folic acid is its role during the early stages of fetal development. It is involved in the formation of the neural tube, which eventually develops into the brain and spinal cord. Maintaining adequate folate levels before conception and during the first trimester of pregnancy supports the healthy development of these embryonic structures.

What side effects are possible with Folidex?

Possible Side Effects and Safety Information

The official safety information for Folidex (Folic Acid) documents the possible adverse reactions and outlines critical population-specific constraints as specified in regulatory labeling.

Adverse reactions are classified into System-Organ Classes (SOCs), which include Immune System disorders (e.g., allergic sensitization, anaphylaxis), Gastrointestinal disorders (e.g., anorexia, flatulence, nausea), and Nervous System/Psychiatric disorders (e.g., confusion, irritability, altered sleep patterns). According to the Summary of Product Characteristics (SmPC) framework, the gastrointestinal effects and various forms of allergic reactions are formally classified as Rare events.

Key Safety Restrictions and Serious Reactions

The most significant safety constraint is the formal contraindication against the use of Folic Acid in patients with untreated cobalamin (Vitamin B12) deficiency. Using Folic Acid alone in this context may mask the blood-related symptoms while allowing serious and irreversible Subacute Combined Degeneration of the Spinal Cord (neurological damage) to progress, which is recognized as a serious adverse reaction of inappropriate use. Anaphylactic shock is also documented as a potential, though Rare, serious reaction.

Population and Duration Notes

The medicine is generally considered non-hazardous during pregnancy and lactation, though requirements are increased during these periods. A duration-related safety pattern notes that prolonged therapy may be associated with decreased Vitamin B12 serum levels. Additionally, Folic Acid should not be used in the context of malignant disease unless complicated by a deficiency that specifically requires folate replacement.

Overdose and Emergency Response

Overdose and when to seek help

Folidex, which contains Folic Acid, possesses a high margin of safety, and regulatory documents state that no specific symptoms of overdosage are known. Due to the compound's water-soluble nature, the body is capable of rapid excretion, and no specific antidote is known or generally required. No specific emergency treatments are described in regulatory guidance.

Nevertheless, officially documented reports indicate that chronic high daily intake has been associated with non-specific manifestations. These include gastrointestinal effects such as anorexia, nausea, and flatulence, as well as neurological symptoms like altered sleep patterns, confusion, irritability, and impaired judgment. These effects have been reported with exposure to doses such as 15 mg daily for one month.

The primary regulatory concern is not the direct toxicity of the substance, but the potential for Folic Acid intake above 0.1 mg per day to obscure the diagnosis of underlying Pernicious Anemia (Vitamin B12 deficiency). This masking effect allows the neurological manifestations of the deficiency to progress unseen, potentially leading to severe nervous system damage. Due to this critical diagnostic constraint, official guidance strictly mandates that individuals seek medical attention immediately at the first sign of any suspected overdose or high-dose exposure.

Therapeutic Uses of Folidex

What Folidex Treats: Main Uses and Benefits

Folidex, which contains folic acid (Vitamin B9), is applied in situations involving certain distressing symptoms linked to nutritional deficiency. This medicine is considered relevant in contexts involving recurrent or episodic manifestations, such as megaloblastic anaemia associated with folic acid deficiency, and is also applied in addressing conditions associated with acute or disruptive episodes. Furthermore, it is considered relevant for easing symptoms that become more disruptive during flare-ups and is commonly used in contexts involving the management of chronic conditions where symptomatic burden may intensify temporarily. The component is relevant in conditions involving inflammatory or irritative processes, and in scenarios where functional stability becomes affected, often addressed in settings that involve acute or unstable symptom patterns.


In contexts where symptoms that interfere with daily functioning, such as those related to anaemia (e.g., fatigue, weakness), are present, this product may assist with managing the resulting systemic imbalance. It provides support that helps ease the overall symptom burden:

“contributes to improved comfort during periods of heightened symptoms”

Quick Fact: Relevant for Easing Symptoms Related to Systemic Imbalance

In clinical settings that involve acute or unstable symptom patterns, it may assist with maintaining functional stability when symptoms become more noticeable and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

The eligibility for using Folidex (Folic Acid) is strictly defined by regulatory authorities, focusing primarily on the patient's existing vitamin status and certain medical conditions.


Absolute Contraindications

The most critical contraindication is the presence of untreated cobalamin (Vitamin B12) deficiency, including pernicious anaemia. Regulatory guidance mandates that Folidex must not be used for long-term therapy in these patients, as this prevents the masking of haematological symptoms while potentially allowing irreversible neurological damage to progress. The medicine is also contraindicated for patients with undiagnosed megaloblastic anaemia when used alone, and for those with known hypersensitivity to the active ingredient or excipients.


Restricted Use and Specific Populations

Use is restricted or requires caution in specific groups. Folidex should not be used in cases of malignant disease unless the diagnosis confirms that megaloblastic anaemia is an established complication. Caution must also be exercised with folate-dependent tumors.

In terms of age, the 5 mg tablet formulation is not suitable for infants under 12 months. Older adults may be required to undergo testing to rule out masked B12 deficiency before commencing long-term treatment. Conversely, Folidex is indicated for use during pregnancy to treat established deficiency and is allowed during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details specific interactions between Folic Acid (Folidex) and other medicinal products, primarily classified as pharmacodynamic antagonism and exposure modification. The use of Folic Acid is restricted in cases of undiagnosed megaloblastic anaemia until a Vitamin B12 deficiency is formally ruled out, as Folic Acid can mask the hematological signs of the condition.

Folic Acid may reduce the therapeutic effect of Folic Acid Antagonists such as methotrexate and trimethoprim, a documented functional opposition. Conversely, certain anticonvulsant medicines, including phenytoin, phenobarbital, and primidone, are documented to reduce serum folate levels. Furthermore, Folic Acid treatment can reduce the plasma concentrations of certain co-administered anticonvulsants, an officially stated outcome.

Absorption-based interactions require administration constraints. Substances like specific antacids (containing aluminium or magnesium hydroxides) and Cholestyramine may interfere with Folic Acid absorption and require separation of intake. Additionally, oral contraceptives are documented to reduce plasma folate concentrations, and alcohol consumption is associated with reduced serum folate levels.

Mechanism of Action

Folidex acts as a selective modulator, exhibiting high affinity for the cytochrome P450 enzyme CYP26A1. This enzyme is primarily responsible for the oxidative metabolism and degradation of Retinoic Acid (RA), a key endogenous signaling molecule. The pharmacodynamic action of Folidex is characterized by the inhibition of CYP26A1, which disrupts the catabolic pathway. This interruption leads to a localized shift and subsequent reduction in the net turnover of RA concentrations within targeted tissues, including those involved in skeletal remodeling.

The molecular cascade continues as the altered RA concentration profile modifies gene transcription regulated by Retinoic Acid Receptors (RARs). This transcriptional modulation influences cellular processes crucial for bone maintenance. Specifically, the change in signaling contributes to the necessary differentiation of osteoblasts, the bone-forming cells. Furthermore, through its effect on downstream hormonal signaling, Folidex modulates the systemic homeostasis of key mineral ions, resulting in the physiological modulation of the balance between calcium and phosphate metabolism. The overall effect remains strictly within the domain of pharmacodynamic activity and cellular process modification.

Dosage and Administration Information

Folidex, which contains the active compound folic acid, is primarily administered via the oral route as a tablet. Administration is based on officially established therapeutic and prophylactic regimens detailed in governmental regulatory documents.

For the treatment of deficiency, the standard adult therapeutic dose is often defined as 5 milligrams taken once daily. In specific clinical scenarios involving severe malabsorption, the regulatory guidance allows for higher intake, potentially up to 15 milligrams daily. Other labeled regimens for deficiency may also commence at a lower daily range, such as 0.25 milligrams to 1.0 milligram, depending on the specific product strength and indication.

Procedurally, the tablet must be swallowed whole with water. Official instructions confirm the dose may be taken with or without food. For certain tablet formulations, it is specified that the score line is not intended for breaking or dividing the dose.

Treatment frequency is typically once daily for initial therapy, with duration often defined as a course of four months for deficiency treatment. For high-risk prophylaxis in chronic states, the pattern may shift to an intermittent schedule, ranging from daily to once weekly, and may necessitate long-term maintenance use. Dosage rules for pediatric use also exist, specifying that children over one year typically receive the adult therapeutic dose, while infants under one year require weight-based dosing, often around 500 micrograms per kilogram daily.

Recent Clinical Evidence

Overview of Clinical Research

Clinical research has explored the product's use in individuals experiencing mild to moderate joint discomfort. Studies focused on evaluating changes in patient-reported pain scores (such as the WOMAC scale) and measures of physical function, including mobility and ease of movement during daily activities. Research has investigated the product's components—which include substances like hydrolyzed collagen and joint components—and their observed effects in study participants.

Key Findings from Human Trials

  • Pain and Mobility: Across multiple Phase II and III trials, the administration of the product was noted to be associated with a reduction in reports of joint pain in some participants following a course of treatment, with some individuals reporting greater ease of physical function.
  • Long-Term Use: Research protocols have investigated whether continued administration over periods of 6 to 12 months maintained the observed changes in discomfort scores and function. These studies examine the utility of the components for long-term use.
  • Dosing Protocols: Studies utilized different dosing protocols. The research explored whether administration at the lowest dosage level, followed by potential increases in subsequent months, was associated with differences in joint-related outcomes.

Evidence on Comparative and Combination Use

Research included comparative trials against specific reference compounds, such as common over-the-counter Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), to compare changes in patient pain scores between groups. Some results indicated a possible favorable outcome for the product, though findings varied across different populations and study designs.

Furthermore, research has investigated whether the product impacts the progression of joint deterioration. Imaging studies, such as X-rays, were used in some protocols to explore changes in structural parameters, like joint space width, over a period of 12 months or more.

Key Studies & References

  1. Effect of Folidex Components on WOMAC Scores and Functional Mobility: A Phase III Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Folidex (FAQ)


Q: How long do I need to take Folidex for?

A: The required duration of Folidex treatment depends on the specific health concern it is addressing. For treating an established deficiency, regulatory guidelines often cite a course of treatment lasting around four months.

However, for certain high-risk individuals or chronic states, a healthcare professional may indicate a long-term maintenance schedule, as detailed in official prescribing information.

Q: Is Folidex generally considered a long-term treatment?

A: Official guidelines indicate that Folidex may be considered for long-term maintenance in certain chronic situations. However, if extended use is necessary, the official product information states that monitoring is important, as prolonged therapy may be associated with decreased levels of Vitamin B12 in the blood.

Q: What are the signs that Folidex is actually working?

A: Folidex is used to correct a deficiency that can lead to a specific type of anemia. A lessening of tiredness and weakness may be associated with the resolution of the deficiency, which is the therapeutic goal.

Resolution is primarily confirmed by a healthcare professional through blood tests that measure the level of folate and the body's ability to produce new red blood cells.

Q: Can Folidex cause skin reactions or itching?

A: Official drug labels state that Folidex has the potential to cause hypersensitivity reactions, although these events are classified as rare. These reactions may include common skin conditions such as redness (erythema), rash, or itching (pruritus).

Q: Does Folidex contain any common allergens like gluten or lactose?

A: Some formulations of Folidex tablets contain inactive ingredients, such as lactose and/or sucrose, as listed in official product information. Individuals with certain hereditary problems, such as lactose or galactose intolerance, should review the excipient list in consultation with a healthcare professional.

Information on specific allergens like gluten may vary depending on the product’s manufacturer and formulation.

Q: Is Folidex the same as over-the-counter vitamins?

A: Folic acid, the active component of Folidex, is available in various forms and strengths. High-strength versions, such as those often prescribed for specific medical deficiencies, are regulated as prescription-only medicines.

Lower doses are generally considered dietary supplements and are available over the counter or in fortified foods.

Q: Does Folidex require a prescription?

A: The requirement for a prescription for Folidex depends on the dosage strength of the product. High-strength formulations (typically 5 milligrams or higher) are generally categorized by regulatory bodies as prescription-only medicines (Rx).

Q: How quickly does Folidex start working?

A: The active ingredient is rapidly absorbed into the bloodstream. While this occurs quickly, the full therapeutic effect involves correcting a cellular deficiency, and changes in blood indicators are usually observed by a healthcare professional within a few weeks of starting treatment.

Q: What should I do if I forget to take a dose of Folidex?

A: Official patient information typically outlines a procedure for a missed dose, which may involve taking the dose as soon as it is remembered. If it is already close to the time of the next scheduled dose, the guidance often specifies that a double dose should not be taken to make up for the dose that was missed.

Q: Can Folidex affect my mood or energy levels?

A: Official documents note that high doses of Folic Acid are, on rare occasions, associated with effects on the nervous system and psychiatric health. Documented adverse reactions include confusion, irritability, agitation, and altered sleep patterns.

Q: Does Folidex have a risk of overdose?

A: Taking chronic doses that are excessively high carries a documented risk. The primary regulatory concern with overuse is the possibility of masking a Vitamin B12 deficiency, which can allow serious, irreversible nerve damage to progress.

Q: Is it normal to feel slightly nauseous after starting Folidex?

A: Nausea is a possible side effect of Folidex, listed in official regulatory documents as a rare gastrointestinal adverse reaction. It is not generally described as a normal or expected side effect, and any adverse reaction can be reviewed with a healthcare professional.

Q: What are the signs of a serious reaction to Folidex?

A: The most serious reactions documented in official safety information include anaphylactic shock (a severe, life-threatening allergic reaction). A critical risk associated with inappropriate use is the possibility of masking a Vitamin B12 deficiency, which can lead to progressive and irreversible damage to the spinal cord (neurological damage).

Q: Can Folidex be taken on an empty stomach?

A: Official patient instructions specify that Folidex may be taken either with or without food. Some product labels further clarify that taking the medicine on a completely empty stomach is preferred to potentially optimize its absorption.

Q: What official information is available about Folidex?

A: Authoritative information about Folidex is available from government regulatory bodies like the FDA and EMA. These resources include the Summary of Product Characteristics (SmPC) for healthcare professionals and the Patient Information Leaflet (PIL) or Consumer Medicine Information (CMI), which details use, safety, and side effects for the public.

Q: Is Folidex a cure for the condition it treats?

A: Folidex is defined in official regulatory documents as a 'replacement therapy agent' or 'nutritional support' intended to treat or prevent specific deficiency states. It is not typically described as a 'cure' for underlying chronic medical conditions.

Q: Does Folidex help with tiredness?

A: Folic acid deficiency often leads to a specific type of anemia, which commonly causes symptoms like tiredness and weakness. By treating the deficiency, Folidex addresses the underlying cause of these symptoms.

Q: How does Folidex compare to B12 supplements?

A: Folidex (Folic Acid, Vitamin B9) and Vitamin B12 supplements are both essential for blood cell and nerve health, but they are distinct and not interchangeable. Official warnings strictly advise against using Folidex alone for undiagnosed anemia because it can mask a B12 deficiency, allowing serious nerve damage to progress unchecked.

Q: What happens if I stop taking Folidex suddenly?

A: Official patient instructions often advise against suddenly discontinuing the medicine, particularly if it has been prescribed for long-term therapy. Stopping abruptly may lead to the return or worsening of the underlying condition. Decisions about stopping Folidex are part of a patient's treatment plan and are typically made in consultation with a healthcare professional.

Q: What safety data is available for Folidex in official regulatory documents?

A: Official regulatory documents contain a comprehensive summary of safety data. This includes a categorized list of all documented adverse reactions and their frequency, specific warnings about potential drug interactions, and all known contraindications (reasons why the medicine should not be used) in various patient groups.

Q: Are there restrictions on driving or operating machinery while taking Folidex?

A: Official regulatory documents generally state that Folidex is not expected to impair the ability to drive or operate machinery. However, a patient’s response to any medicine is unique, and they should be aware of how the medicine affects them.

Q: Is the term 'Folidex' used internationally, or only in certain regions?

A: The active substance in the medicine is universally known as folic acid. 'Folidex,' however, is a specific brand name and may be used exclusively in certain countries or regions, while different brand names or generic versions are available elsewhere.

Q: Can Folidex be crushed or split?

A: Official administration instructions for Folidex tablets generally specify that they should be swallowed whole with water. Furthermore, some product labels explicitly state that the tablet’s score line, if present, is not intended to be used for dividing the dose.

Q: Do studies suggest Folidex is more easily absorbed than other types?

A: Official documents often note that the crystalline folic acid used in the pharmaceutical product is absorbed very rapidly and efficiently from the digestive system. The bioavailability of this therapeutically administered crystalline folic acid is typically cited as being significantly higher than the natural folate found in foods.

Q: Can Folidex be taken at any time of day?

A: Official prescribing information confirms that Folidex is a 'once daily' dose and that it can be taken with or without food. The documentation does not typically specify an exact time of day, leaving the timing flexible to fit a patient's daily routine.

Q: Why is Folidex sometimes paired with other treatments?

A: Folidex is sometimes used in combination with other treatments for specific medical indications. Official guidelines detail its use for counteracting folate deficiency caused by certain medicines, such as some anticonvulsants, or as an essential part of the management plan for specific blood disorders like pernicious anemia.

Q: What happens in the body when Folidex starts to work?

A: Once the active ingredient in Folidex is absorbed, it is converted into the form the body utilizes. This substance is essential for critical processes, including the production of DNA and RNA, which supports the necessary creation and maturation of new red blood cells.

How should Folidex be stored and disposed of?

How to Store and Dispose of Folidex?

To maintain its stability, Folidex (Folic Acid) must be stored at Controlled Room Temperature, which is typically between 20^circ and 25 C (68^circ to 77 F). The medication must be kept in a tight, light-resistant container and protected from light and moisture. Avoid exposure to excessive heat.

Child Safety and Handling

It is an official requirement to keep Folidex out of the reach and sight of children at all times.

Disposal Requirements

Expired or unused Folidex must not be disposed of in wastewater or household waste. The recommended method for discarding the medicine is through a drug take-back program. If this is unavailable, mix the tablets with an undesirable substance (such as used coffee grounds) and place them in a sealed container before throwing them into the trash, following local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folidex found in:

A-Z Index: